
|Videos|March 4, 2021
Find out more about Allergan’s presbyopia drop NDA filing
Potential presbyopia treatment coming
Advertisement
Learn more about the recent new drug application (NDA) Allergan submitted for its investigational eyedrop to treat presbyopia. Optometry Times® Editor in Chief Gretchyn Bailey, NCLC, FAAO, chats with Michael Robinson, MD, vice president, global therapeutic area head of ophthalmology at Allergan, to get details on when ODs could discuss a potential presbyopia treatment with their patients.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Deseyne EDOF daily contact lenses first of its kind approved by US FDA
2
GSLS 2026: Seeking the best lens fit for patients with HOAs
3
What’s new in 2025-2026: Ophthalmic drugs and drug delivery systems
4
GSLS 2026: Enhancing visual quality in keratoconus
5














































